AU2001244613A1 - Novel process for producing fused imidazopyridine derivative and novel crystal form - Google Patents

Novel process for producing fused imidazopyridine derivative and novel crystal form

Info

Publication number
AU2001244613A1
AU2001244613A1 AU2001244613A AU4461301A AU2001244613A1 AU 2001244613 A1 AU2001244613 A1 AU 2001244613A1 AU 2001244613 A AU2001244613 A AU 2001244613A AU 4461301 A AU4461301 A AU 4461301A AU 2001244613 A1 AU2001244613 A1 AU 2001244613A1
Authority
AU
Australia
Prior art keywords
novel
crystal form
producing fused
imidazopyridine derivative
novel process
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001244613A
Inventor
Fumihiko Matsubara
Takashi Ohya
Masaaki Uenaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of AU2001244613A1 publication Critical patent/AU2001244613A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AU2001244613A 2000-03-30 2001-03-29 Novel process for producing fused imidazopyridine derivative and novel crystal form Abandoned AU2001244613A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000092565 2000-03-30
JP2000-92565 2000-03-30
PCT/JP2001/002620 WO2001074821A1 (en) 2000-03-30 2001-03-29 Novel process for producing fused imidazopyridine derivative and novel crystal form

Publications (1)

Publication Number Publication Date
AU2001244613A1 true AU2001244613A1 (en) 2001-10-15

Family

ID=18607880

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001244613A Abandoned AU2001244613A1 (en) 2000-03-30 2001-03-29 Novel process for producing fused imidazopyridine derivative and novel crystal form

Country Status (17)

Country Link
US (1) US7049437B2 (en)
EP (1) EP1270578A4 (en)
JP (1) JP3481930B2 (en)
KR (1) KR20020082898A (en)
CN (1) CN1203073C (en)
AU (1) AU2001244613A1 (en)
BR (1) BR0109643A (en)
CA (1) CA2403131A1 (en)
CZ (1) CZ20023276A3 (en)
HK (1) HK1054387A1 (en)
HU (1) HUP0300580A3 (en)
IL (1) IL151877A0 (en)
MX (1) MXPA02009460A (en)
NO (1) NO20024623L (en)
PL (1) PL357672A1 (en)
WO (1) WO2001074821A1 (en)
ZA (1) ZA200207295B (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6987187B2 (en) 2001-07-16 2006-01-17 Shionogi & Co., Ltd. Process for preparation of amidine derivatives
JPWO2004078173A1 (en) * 2003-02-05 2006-06-08 塩野義製薬株式会社 Tablets with improved dissolution
JP2007502293A (en) 2003-08-12 2007-02-08 スリーエム イノベイティブ プロパティズ カンパニー Hydroxylamine-substituted imidazo-containing compounds
EP1658076B1 (en) 2003-08-27 2013-03-06 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted imidazoquinolines
CA2537763A1 (en) 2003-09-05 2005-03-17 3M Innovative Properties Company Treatment for cd5+ b cell lymphoma
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
AR046046A1 (en) 2003-10-03 2005-11-23 3M Innovative Properties Co IMIDAZOQUINOLINAS ALCOXI SUBSTITUTED. PHARMACEUTICAL COMPOSITIONS.
CA2545774A1 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Oxime substituted imidazo ring compounds
CA2545825A1 (en) * 2003-11-14 2005-06-02 3M Innovative Properties Company Hydroxylamine substituted imidazo ring compounds
BRPI0416936A (en) 2003-11-25 2007-01-16 3M Innovative Properties Co substituted imidazo ring systems and methods
EP1701955A1 (en) 2003-12-29 2006-09-20 3M Innovative Properties Company Arylalkenyl and arylalkynyl substituted imidazoquinolines
EP1699788A2 (en) 2003-12-30 2006-09-13 3M Innovative Properties Company Imidazoquinolinyl, imidazopyridinyl and imidazonaphthyridinyl sulfonamides
AU2005228150A1 (en) 2004-03-24 2005-10-13 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
US20080058281A1 (en) * 2004-03-30 2008-03-06 Yates Paula R Skin Lightening Compositions Comprising Vitamines and Flavonoids
WO2005123080A2 (en) 2004-06-15 2005-12-29 3M Innovative Properties Company Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
WO2006065280A2 (en) 2004-06-18 2006-06-22 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
WO2006038923A2 (en) 2004-06-18 2006-04-13 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
WO2006009832A1 (en) * 2004-06-18 2006-01-26 3M Innovative Properties Company Substituted imidazo ring systems and methods
WO2006009826A1 (en) 2004-06-18 2006-01-26 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
US8034938B2 (en) 2004-12-30 2011-10-11 3M Innovative Properties Company Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
JP5543068B2 (en) 2004-12-30 2014-07-09 スリーエム イノベイティブ プロパティズ カンパニー Chiral fused [1,2] imidazo [4,5-c] cyclic compound
US9248127B2 (en) 2005-02-04 2016-02-02 3M Innovative Properties Company Aqueous gel formulations containing immune response modifiers
EP1846405A2 (en) 2005-02-11 2007-10-24 3M Innovative Properties Company Oxime and hydroxylamine substituted imidazo 4,5-c ring compounds and methods
CA2602590A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
US7943610B2 (en) 2005-04-01 2011-05-17 3M Innovative Properties Company Pyrazolopyridine-1,4-diamines and analogs thereof
AU2006292119A1 (en) * 2005-09-23 2007-03-29 3M Innovative Properties Company Method for 1H-imidazo[4,5-c]pyridines and analogs thereof
WO2008008432A2 (en) 2006-07-12 2008-01-17 Coley Pharmaceutical Group, Inc. Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378848A (en) * 1992-02-12 1995-01-03 Shionogi & Co., Ltd. Condensed imidazopyridine derivatives
US5658903A (en) * 1995-06-07 1997-08-19 Smithkline Beecham Corporation Imidazole compounds, compositions and use

Also Published As

Publication number Publication date
HUP0300580A3 (en) 2006-06-28
PL357672A1 (en) 2004-07-26
HK1054387A1 (en) 2003-11-28
CN1419557A (en) 2003-05-21
IL151877A0 (en) 2003-04-10
CN1203073C (en) 2005-05-25
BR0109643A (en) 2003-04-22
US20030088102A1 (en) 2003-05-08
NO20024623D0 (en) 2002-09-26
JP3481930B2 (en) 2003-12-22
KR20020082898A (en) 2002-10-31
EP1270578A4 (en) 2004-11-03
US7049437B2 (en) 2006-05-23
HUP0300580A2 (en) 2003-07-28
ZA200207295B (en) 2003-09-11
WO2001074821A1 (en) 2001-10-11
NO20024623L (en) 2002-11-08
CA2403131A1 (en) 2001-10-11
MXPA02009460A (en) 2003-02-12
EP1270578A1 (en) 2003-01-02
CZ20023276A3 (en) 2003-02-12

Similar Documents

Publication Publication Date Title
AU2001244613A1 (en) Novel process for producing fused imidazopyridine derivative and novel crystal form
AU2001256732A1 (en) Process for producing crystal
WO2001083388A8 (en) Glass preform and methods and apparatus for manufacture thereof
AU2001227573A1 (en) Ceramics and process for producing
AU2001284514A1 (en) Process for producing ester
AU5848100A (en) Method for producing quartz glass member and quartz glass member produced thereby
HUP0300475A3 (en) Novel stable crystal of thiazolidinedione derivative and process for producing the same
AU2001230207A1 (en) Method for the production of 1-amino-3-aryl-uracils
AU2001291313A1 (en) Process for making 3-amino-2-chloro-4-methylpyridine
AU2002214329A1 (en) Process for producing potassium fluoroniobate crystal and potassium fluoroniobate crystal
AU2001272757A1 (en) Process for producing 5-fluorooxyindole and for producing intermediate therefor
AU3734301A (en) Method for producing 2-chloro-benzimidazole derivatives
AU2001264134A1 (en) Microconnectors and method for their production
AU2002212874A1 (en) High strength ceramised glass and method for production thereof
AU2001242735A1 (en) Process for producing camptothecin
AU2002229149A1 (en) Process for producing hydrazinomonosaccharide derivatives and use thereof
AU2001280244A1 (en) Novel process for preparing 3-aminomethyl-4-z-methoxyiminopyrrolidine
AU2001234159A1 (en) Process for producing quinolonecarboxylic acids and intermediates thereof
AU2001226654A1 (en) Process for preparing esters
AU2001284442A1 (en) Process for producing fluoroalkanol
AU2002217463A1 (en) Process for producing allumium extracts
AU4105701A (en) Process for producing carbapenem derivatives
AU2002211034A1 (en) Aziridinylquinolinedione derivatives and process for their preparation
AU5065001A (en) Process for producing alpha-l-aspartyl-l-phenylalanine methylester hydrochloride
AU2001295925A1 (en) Process for producing diacetoxybutene